Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb 1;59(2):161-9.
doi: 10.1097/QAI.0b013e3182427029.

Unresolved antiretroviral treatment management issues in HIV-infected children

Affiliations
Review

Unresolved antiretroviral treatment management issues in HIV-infected children

Shirin Heidari et al. J Acquir Immune Defic Syndr. .

Abstract

Antiretroviral therapy in children has expanded dramatically in low-income and middle-income countries. The World Health Organization revised its pediatric HIV guidelines to recommend initiation of antiretroviral therapy in all HIV-infected children younger than 2 years, regardless of CD4 count or clinical stage. The number of children starting life-long antiretroviral therapy should therefore expand dramatically over time. The early initiation of antiretroviral therapy has indisputable benefits for children, but there is a paucity of definitive information on the potential adverse effects. In this review, a comprehensive literature search was conducted to provide an overview of our knowledge about the complications of treating pediatric HIV. Antiretroviral therapy in children, as in adults, is associated with enhanced survival, reduction in opportunistic infections, improved growth and neurocognitive function, and better quality of life. Despite antiretroviral therapy, HIV-infected children may continue to lag behind their uninfected peers in growth and development. In addition, epidemic concurrent conditions, such as tuberculosis, malaria, and malnutrition, can combine with HIV to yield more rapid disease progression and poor treatment outcomes. Additional studies are required to evaluate the long-term effects of antiretroviral therapy in HIV-infected infants, children, and adolescents, particularly in resource-limited countries where concomitant infections and conditions may enhance the risk of adverse effects. There is an urgent need to evaluate drug-drug interactions in children to determine optimal treatment regimens for both HIV and coinfections.

PubMed Disclaimer

Conflict of interest statement

L.M.M., C.V.H., and E.K. have no competing interests.

Similar articles

Cited by

References

    1. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:1915–1927. - PMC - PubMed
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector—Progress Report 2010. Geneva, Switzerland: UNAIDS; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf. Accessed January 3, 2011.
    1. World Health Organization (WHO) Progress Report 2009. WHO; Geneva, Switzerland: 2009. Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Available at: http://www.who.int/hiv/pub/tuapr_2009_en.pdf. Accessed August 4, 2010.
    1. Violari A, Cotton MF, Gibb DM, et al. CHER Study Team Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–2244. - PMC - PubMed
    1. World Health Organization (WHO) Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. Geneva, Switzerland: WHO; 2008. Available at: http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_m.... Accessed September 10, 2010.

Publication types

Substances